Humacyte, Inc.

NASDAQ:HUMA

2.59 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -148.701-110.776-11.965-26.477-66.524-85.422
Depreciation & Amortization 7.197.7198.218.2418.3516.749
Deferred Income Tax 00-0.173-17.8010.177-4.272
Stock Based Compensation 6.1376.8286.18410.1464.6944.457
Change In Working Capital 0.3116.5711.029-0.557-2.3690.453
Accounts Receivables 00.0310.145-0.0630.488-0.185
Inventory 000-0.181-2.257-2.434
Accounts Payables -1.9624.811-0.509-0.197-0.8892.434
Other Working Capital 2.2731.7291.393-0.1160.2890.638
Other Non Cash Items 36.94116.353-74.414-54.7420.1031.976
Operating Cash Flow -98.122-73.305-71.129-81.19-55.568-71.787
Investing Activities:
Investments In Property Plant And Equipment -1.572-2.28-1.048-0.22-0.318-8.125
Acquisitions Net 00-5.89300.050
Purchases Of Investments 00-10.107-800
Sales Maturities Of Investments 02.10716000
Other Investing Activites 005.893-80.050
Investing Cash Flow -1.572-0.1734.845-8.22-0.268-8.125
Financing Activities:
Debt Repayment -2.579-34.066-1.98127.931.751-1.292
Common Stock Issued 45.9260.5660.5350.5980.3010
Common Stock Repurchased 0.70800000
Dividends Paid 000000
Other Financing Activities 70.83638.5730.535239.0530.3011.218
Financing Cash Flow 114.1834.507-1.446266.9832.052-0.074
Other Information:
Effect Of Forex Changes On Cash 00000173.699
Net Change In Cash 14.489-68.971-67.73177.573-53.784-79.986
Cash At End Of Period 95.2980.801149.772217.50239.92993.713